Myfembree is the newest prescription medicine used to control heavy menstrual bleeding due to uterine fibroids
It is used only in premenopausal women and is not designed for women in menopause who have medical issues with uterine fibroids
Because of the effects long term health, it has only been approved for use up to 24 months.
Myfembree contains relugolix, which mimics the effect of certain hormonal controls of the ovarian cycles and thus when taken it ultimately reduces the amount of estrogen (and other hormones) produced by ovaries.
To minimize the effect of the medication relugolix which affects the uterine fibroids, the medication also contains hormones in oral contraceptives including both estradiol (an estrogen) which may reduces hormonal risks of bone loss, hot flashes, effects on vaginal dryness, and effects on the cardiovascular system, and norethindrone acetate (a progestin) which is necessary to protect the lining of the uterus in women who take estrogen.
There are other medications in this class that are available to control the bleeding. Be evaluated for anemia, and other complications of fibroids, and consult your gynecologist to determine the best way to monitor and treat your uterine fibroids. Desire for future fertility may play a role in what treatments are best for you.